GC001
/ Hangzhou Gongchu Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 28, 2024
A Phase I Clinical Study of Intratumoral Injection GC001 in Patient With Recurrent or Progressive Gliomas
(clinicaltrials.gov)
- P1 | N=35 | Recruiting | Sponsor: GONGCHU Biotechnology Co., Ltd
New P1 trial • Oncolytic virus • Brain Cancer • CNS Tumor • Glioma • Oncology • Solid Tumor • CD4 • IFNG • IL10 • IL6 • PD-1 • TNFA
1 to 1
Of
1
Go to page
1